CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-23 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −5,530 | $25.03 | $138K | 64,273 |
| 2024-07-23 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −7,924 | $26.36 | $209K | 56,349 |
| 2024-07-23 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −8,446 | $27.10 | $229K | 47,903 |
| 2024-07-23 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −100 | $27.87 | $3K | 47,803 |
| 2024-07-23 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −22,000 | 60,217 | ||
| 2024-07-15 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award | +480 | $15.65 | $8K | 22,254 |
| 2024-07-15 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award 10b5-1 | +211 | $15.65 | $3K | 18,391 |
| 2024-06-06 | Cole G Bradley Director | Option exercise | +4,373 | 9,373 | ||
| 2024-06-06 | Cole G Bradley Director | Option exercise · Restricted Share Units | −4,373 | 0 | ||
| 2024-06-06 | Levy Richard S Director | Option exercise | +4,373 | 12,897 | ||
| 2024-06-06 | Levy Richard S Director | Option exercise · Restricted Share Units | −4,373 | 0 | ||
| 2024-06-06 | Malley Thomas Director | Option exercise | +4,373 | 9,373 | ||
| 2024-06-06 | Malley Thomas Director | Option exercise · Restricted Share Units | −4,373 | 0 | ||
| 2024-06-06 | McCain Tracey L Director | Option exercise | +4,373 | 9,373 | ||
| 2024-06-06 | McCain Tracey L Director | Option exercise · Restricted Share Units | −4,373 | 0 | ||
| 2024-06-06 | Popovits Kimberly J Director | Option exercise | +4,373 | 9,373 | ||
| 2024-06-06 | Popovits Kimberly J Director | Option exercise · Restricted Share Units | −4,373 | 0 | ||
| 2024-06-06 | Quart Barry D Director | Option exercise | +4,373 | 9,373 | ||
| 2024-06-06 | Quart Barry D Director | Option exercise · Restricted Share Units | −4,373 | 0 | ||
| 2024-06-05 | Cole G Bradley Director | Grant or award · Share Option | +19,040 | 19,040 |
Page 50 of 74 · 1,467 trades